“…These include b1-integrin (Hannigan et al, 1996), myelin basic protein (Hannigan et al, 1996); b-parvin (Yamaji et al, 2001); glycogen synthase kinase-3b (GSK-3b) (Delcommenne et al, 1998); Akt (Persad et al, 2001); the regulatory light chain of myosin-II, MLC-20 ; the protein phosphatase-inhibitory proteins CPI-17, PHI-1 and KEPI (Erd + odi et al, 2003); the myosin-targeting subunit of the myosin (Attwell et al, 2003) Lactation, mammary differentiation (Akhtar et al, 2009) Smooth-muscle contraction; MLC-20 phosphorylation Eto, 2009) Mitotic spindle organization (Fielding et al, , 2011) Renal agenesis (Lange et al, 2009) Akt Ser473 phosphorylation, cell survival (Persad et al, 2000(Persad et al, , 2001) Zebrafish muscle fiber-ECM adhesion (Postel et al, 2008) Human cardiomyopathy (Knoll et al, 2007) (Zervas et al, 2001) Inhibition of growth, and apoptosis of anaplastic thyroid cancer cells (Younes et al, 2005) Pancreatic cancer xenograft apoptosis (Yau et al, 2005) Mammary tumor growth (White et al, 2001) Abbreviation: ILK, integrin-linked kinase. Evidence for kinase dependence is based on effects of point mutations predicted or shown to affect catalytic function, or inhibition by the QLT class of inhibitor, with or without corroborating genetic knockout/knockdown data.…”